SAS10 inhibitors represent a distinct class of chemical compounds that specifically target the SAS10 protein, which plays a crucial role in ribosome biogenesis. Ribosomes, the cellular machinery responsible for protein synthesis, are formed through intricate processes involving multiple proteins and RNA components. SAS10 is an integral part of the small subunit (SSU) processome, a precursor complex essential for the formation of the small subunit of the ribosome. Given the significance of SAS10 in this complex biological process, the modulation of its activity has garnered attention in molecular biology and biochemistry fields.
The SAS10 inhibitors function by binding to the SAS10 protein or its interacting partners, thereby modulating its activity and potentially affecting ribosome biogenesis. These inhibitors can be small organic molecules, nucleotide analogs, or other chemical entities that can interact with the protein's active or allosteric sites. The specificity of these compounds to SAS10 is paramount to ensure that off-target effects are minimized, providing a clear view of the protein's function when it is inhibited. Advanced techniques, such as molecular docking and computational modeling, have facilitated the prediction and understanding of how these molecules interact with SAS10. As science continues to advance, it's anticipated that the catalog of SAS10 inhibitors will expand, offering a deeper insight into the role of SAS10 in cellular processes and how its modulation can impact broader cellular functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA synthesis. By preventing transcription, it could reduce the expression of proteins, including SAS10. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin intercalates into DNA, disrupting DNA replication and RNA transcription, which may lead to decreased expression of proteins like SAS10. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, an enzyme essential for DNA replication. This can lead to reduced gene expression and potentially inhibit SAS10 production. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to DNA and inhibits RNA polymerase, which can reduce transcription and potentially lower SAS10 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that affects chromatin structure and gene expression. It could potentially downregulate SAS10 expression. | ||||||
Griseofulvin | 126-07-8 | sc-202171A sc-202171 sc-202171B | 5 mg 25 mg 100 mg | $83.00 $216.00 $586.00 | 4 | |
Griseofulvin disrupts microtubule function and can interfere with mitosis. This can affect general protein synthesis and potentially reduce SAS10 expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, affecting DNA synthesis. This disruption can lead to reduced gene expression, including SAS10. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases, impacting cell cycle and gene expression. This might reduce SAS10 expression. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $82.00 $300.00 $1082.00 | 30 | |
Aphidicolin is a DNA polymerase inhibitor that can prevent DNA replication and thereby affect gene expression, potentially inhibiting SAS10. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Geldanamycin inhibits heat shock protein 90 (Hsp90), a chaperone protein. This can disrupt the proper folding of various proteins, possibly affecting SAS10 expression. |